Showing results (151-160 of 304) with videos related to
Sort By:
Pageof 31
Laboratory Animals|August 26, 2010
An updated and simplified method for bile duct cannulation of ratsH Tønsberg, R Holm, T G Bjerregaard, et al.Journal of Clinical Pathology|May 27, 2005
Markers of apoptosis in stage IB squamous cervical carcinomaG Van de Putte, R Holm, A K Lie, et al.Ultrastructural Pathology|January 1, 1985
Breast carcinomas with neuroendocrine differentiationJ M Nesland, V A Memoli, R Holm, et al.The Laryngoscope|March 26, 2026
Quantifying Dehydration Effects of Porcine Vocal Fold Attenuation With Optical Coherence TomographyOwen P Wischhoff, Michael Kuang, Brady D Prosser, et al.Acta Oncologica (Stockholm, Sweden)|July 31, 1999
HPV positive bronchopulmonary carcinomas in women with previous high-grade cervical intraepithelial neoplasia (CIN III)E M Hennig, Z Suo, F Karlsen, et al.The Journal of Pathology|January 1, 1993
Immunohistochemical analysis of p53 protein overexpression in normal, premalignant, and malignant tissues of the cervix uteriR Holm, H Skomedal, A Helland, et al.Anticancer Research|May 16, 2000
P-glycoprotein expression is a marker for chemotherapy resistance and prognosis in advanced ovarian cancerM M Baekelandt, R Holm, J M Nesland, et al.Pediatric Allergy and Immunology : Official Publication of the European Society of Pediatric Allergy and Immunology|June 25, 2021
A role for metabolism in determining neonatal immune functionSean R Holm, Ben J Jenkins, James G Cronin, et al.Journal of Neuroimmunology|November 5, 2021
Immunological effects of dimethyl fumarate treatment in blood and CSF of patients with primary progressive MSJ Talbot, H Højsgaard Chow, R Holm Hansen, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|September 22, 2000
Levels of cyclin D1 and D3 in malignant melanoma: deregulated cyclin D3 expression is associated with poor clinical outcome in superficial melanomaV A Flørenes, R S Faye, G M Maelandsmo, et al.Pageof 31